Brain tumor research HQ to be built on St. Joseph’s Phoenix campus
The Ivy Brain Tumor Center at Barrow Neurological Institute plans to build its 75,000-square-foot global headquarters on the campus of St. Joseph’s Hospital and Medical Center in Phoenix.
With total development costs ranging between $40 million and $50 million, the new headquarters will be financed through the Ben & Catherine Ivy Foundation, Barrow Neurological Foundation and the world-renowned Barrow Neurological Institute.
The brain tumor center currently takes space within three buildings totaling 12,000 square feet on the Dignity Health St. Joseph’s campus. The new headquarters will bring the program under one roof at the corner of Thomas Road and Third Avenue.
The five-story building will be the largest translational research center dedicated to brain tumor drug development in the world, said Dr. Nader Sanai, director of the Ivy Brain Tumor Center and a neurosurgical oncologist at BNI.
Founded three years ago, the Ivy Brain Tumor Center employs 44 full-time scientists, investigators and operational staff.
Screening and treating more than 1,000 patients since its inception, the center is collaborating with more than 25 biopharma companies and opening 11 new clinical trials that will offer local patients an opportunity to try investigative treatments.
The additional space will allow the center to maximize capacity to engage more new agents and partnerships, conduct trials even faster and expand patient diversity, Sanai said.
Phoenix Mayor Kate Gallego told the Business Journal that the global headquarters is an exciting addition to the life-saving research being conducted in Phoenix, which can serve as both an innovation hub and global connector for the Ivy Center to call home.
“I believe the road to curing cancer runs through Phoenix, and this brings us one step closer to that cure,” Gallego said.
This article was originally published by Phoenix Business Journal.